CORRECTION: Biohit Oyj - Managers' Transactions

Report this content

Biohit Oyj - Managers' Transactions, March 1, 2017 at 1:55 pm local time (EET)

CORRECTION TO BIOHIT OYJ – MANAGER’S TRANSACTIONS IN MARCH 1, 2017 AT 11:45 AM LOCAL TIME (EET)

Transaction details 27.2.2017 should read as follows:

Transaction Details

(1): Volume: 92 Unit price: 5,40000 EUR

(2): Volume: 95 Unit price: 5,40000 EUR

(3): Volume: 500 Unit price: 5,41000 EUR

(4): Volume: 208 Unit price: 5,42000 EUR

(5): Volume: 550 Unit price: 5,44000 EUR

(6): Volume: 150 Unit price: 5,45000 EUR

(7): Volume: 50 Unit price: 5,45000 EUR

(8): Volume: 140 Unit price: 5,50000 EUR

(9): Volume: 50 Unit price: 5,50000 EUR

(10): Volume: 400 Unit price: 5,51000 EUR

(11): Volume: 540 Unit price: 5,52000 EUR

(12): Volume: 150 Unit price: 5,55000 EUR

(13): Volume: 19 Unit price: 5,55000 EUR

(14): Volume: 10 Unit price: 5,55000 EUR

 

Aggregated transactions

(14): Volume: 2954 Volume weighted average price: 5.46629 EUR

The release including the corrected information is found in its entirety

below.

 

Additional information: 
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861

investor.relations@biohit.fi
www.biohithealthcare.com

 

 

Person subject to the notification requirement
Name: Korpela, Semi  
Position: Chief Executive Officer
     
Initial Notification  
Reference number: 74370089ATTSNBXJVT29_20170301133927_24
     
Issuer
Name: Biohit Oyj
LEI: 74370089ATTSNBXJVT29
     
Transaction details
Transaction date: 2017-02-24
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)
 
Instrument: Share
ISIN: FI0009005482
 
Volume: 206
Unit price: 5,61000 Euro
Volume: 258
Unit price: 5,61000 Euro
Volume: 278
Unit price: 5,61000 Euro
Volume: 397
Unit price: 5,61000 Euro
Volume: 500
Unit price: 5,61000 Euro
Volume: 35
Unit price: 5,61000 Euro
Volume: 188
Unit price: 5,61000 Euro
Volume: 465
Unit price: 5,59000 Euro
Volume: 500
Unit price: 5,58000 Euro
Volume: 246
Unit price: 5,65000 Euro
Volume: 298
Unit price: 5,62000 Euro
Volume: 99
Unit price: 5,56000 Euro
Volume: 49
Unit price: 5,56000 Euro
Volume: 500
Unit price: 5,56000 Euro
Volume: 352
Unit price: 5,57000 Euro
Volume: 400
Unit price: 5,62000 Euro
 
Aggregated transactions
Volume: 4771
Volume weighted average price: 5.59869 Euro
     
Transaction details
Transaction date: 2017-02-27
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)
 
Instrument: Share
ISIN: FI0009005482
 
Volume: 92
Unit price: 5,40000 Euro
Volume: 95
Unit price: 5,40000 Euro
Volume: 500
Unit price: 5,41000 Euro
Volume: 208
Unit price: 5,42000 Euro
Volume: 550
Unit price: 5,44000 Euro
Volume: 150
Unit price: 5,45000 Euro
Volume: 50
Unit price: 5,45000 Euro
Volume: 140
Unit price: 5,50000 Euro
Volume: 50
Unit price: 5,50000 Euro
Volume: 400
Unit price: 5,51000 Euro
Volume: 540
Unit price: 5,52000 Euro
Volume: 150
Unit price: 5,55000 Euro
Volume: 19
Unit price: 5,55000 Euro
Volume: 10
Unit price: 5,55000 Euro
 
Aggregated transactions
Volume: 2954
Volume weighted average price: 5.46629 Euro
     
Transaction details
Transaction date: 2017-02-28
Venue: NASDAQ HELSINKI LTD (XHEL)
Nature of the transaction: Exercise (Rights, Put and Call Options)
 
Instrument: Share
ISIN: FI0009005482
 
Volume: 268
Unit price: 5,32000 Euro
Volume: 281
Unit price: 5,32000 Euro
Volume: 50
Unit price: 5,32000 Euro
Volume: 177
Unit price: 5,30000 Euro
Volume: 662
Unit price: 5,30000 Euro
Volume: 282
Unit price: 5,31000 Euro
Volume: 404
Unit price: 5,31000 Euro
Volume: 338
Unit price: 5,30000 Euro
Volume: 85
Unit price: 5,31000 Euro
Volume: 200
Unit price: 5,33000 Euro
Volume: 180
Unit price: 5,35000 Euro
Volume: 77
Unit price: 5,35000 Euro
Volume: 800
Unit price: 5,35000 Euro
Volume: 120
Unit price: 5,36000 Euro
Volume: 533
Unit price: 5,35000 Euro
Volume: 125
Unit price: 5,36000 Euro
 
Aggregated transactions
Volume: 4582
Volume weighted average price: 5.32617 Euro

 

Additional information: 

CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861

investor.relations@biohit.fi
www.biohithealthcare.com


Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com

Subscribe